Comparison of cabozantinib with axitinib as second-line treatment for metastatic kidney cancer
To date, there have not been any studies that have [...]
Expert interview about cancer vaccines
In this very interesting interview from the Friends of Renal [...]
NHS England Cancer Programme progress update – Spring 2024
The NHS England Cancer Programme has released a report NHS [...]
New PET imaging agent for kidney cancer
Researchers are looking for better ways to diagnose kidney cancer. Currently, diagnosis is [...]
Factors affecting outcomes after nephrectomy for metastatic kidney cancer
Nephrectomy is surgery to remove all or part of a [...]
The ‘mystery’ culprit causing kidney cancer worldwide
This article from Cancer Research UK talks about the search [...]
New cancer vaccine in development
A new vaccine is being heralded as a 'game changer’ [...]
Sick pay – cancer patients are counting the cost
Statutory Sick Pay: New briefing lifts the lid on the [...]
Lenvatinib plus everolimus for patients with metastatic kidney cancer
The treatment of heavily pretreated patients with metastatic kidney cancer [...]
Adjuvant pembrolizumab prolongs overall survival for kidney cancer patients
Surgery (partial or radical nephrectomy) is the standard of care [...]
